Abstract:Abstract The serine protease granzyme B (GrB) is a powerful enzymatic inducer of apoptosis via a multi-modal intracellular mechanism including direct activation of the caspase cascade, damaging mitochondria resulting in the release of cytochrome C, and damaging nuclear matrix. We developed a novel recombinant immunotoxin linking GrB to a humanized Herceptin-derived scFv (4D5) specific for the Her2/neu cell-surface domain. The GrB/4D5 fusion constructs were efficiently expressed in HEK 293T mammalian cells as active glycosylated molecules and purified by immobilized cobalt affinity chromatography. In vitro studies demonstrated that GrB/4D5 retained the affinity and specificity of the original Herceptin antibody with a Kd of 0.24nM, as well as the biological activity of GrB (BAADT assay, enzymatic activity of 2.08×105U/µM, vs 1.39×105U/µM for free GrB). Target cell-specific activity was observed with IC50 of 10 to 50nM against a panel of Her2/neu positive tumor cells. In addition, the rapid induction of apoptosis in cells was confirmed by Annexin V staining and detection of activated caspase-3 in the cytosol. GrB/4D5 was active against BT474 M1 parental cells as well as Herceptin-resistant cells, despite the fact that these cells were more than 150 fold resistant to Herceptin. Addition of EGF or NRG-1 had no inhibitory effect on the cytotoxicity of the fusion construct against BT474 M1 cells. This is the first report of GrB-based immunotoxins having the potential to overcome Herceptin resistance arising in breast tumor cells. Further in vitro characterization against Her2/neu positive cancer cells expressing MDR or MRP-related proteins and in vivo xenograft model studies are ongoing. Research conducted, in part, by the Clayton Foundation for Research. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3870. doi:1538-7445.AM2012-3870

[Construction and Expression of Recombinant Antibody/granzyme B Containing Truncated Translocating Peptide].

Expression of Two Chimeric Human Granzyme B Genes and Their Killing Activities of Tumor Cells

[Construction, Expression and Cell Growth Inhibition of Translocating Peptide/granzyme B Fusion Protein Gene].

Expression of Human Granzyme B Gene in HeLa Cells

[Growth Inhibitory Effects of Recombinant Granzyme B Containing Different N-terminal Translocating Peptides].

Cloning,Purification and Prokaryotic Expression of Human Granzyme B Gene

Secreted Antibody/granzyme B Fusion Protein Stimulates Selective Killing of HER2-overexpressing Tumor Cells.

Expression of a Chimeric Gene Containing Poly-Arginine As the Protein Transduction Domain and Its Killing Activity Against HER2 Positive Gastric Cancer SGC-7901 Cells

Establishment of Hela cell line inducibly expressing human active granzyme B

HER2-targeting Recombinant Protein with Truncated Pseudomonas Exotoxin: A Translocation Domain Efficiently Kills Breast Cancer Cells

Ectopic Expression of Active Granzyme B Gene Leads to Multinuclear Giant Cels

[Construction and Expression of Prokaryotic Vector of Single Chain Antibody Derived from a New Clone of Anti-Cd14 Antibody ZCH-7-2F9].

Construction and Expression of Single-Chain Antibody Derived from a New Clone of Monoclonal Antibody Against Human CD14 in CHO Cells

[Construction of Recombinant GST-RCAS1 Fusion Gene and Its Expression in E. Coli].

Construction and Biological Function of Eukaryotic Expression Vector for Myctagged HER2

Abstract 3870: Construction and Characterization of Completely Human Serine Protease Therapeutics Targeting Her2/neu

Construction of recombinant expression vector of granulysin gene and its prokaryotic expression

[Expression of Modified Humanized Immunoapoptotic Protein and Its Specific Killing Effect on HER2-positive Tumor Cells].

Construction of Apoptin Fusion Gene Prokaryotic Expression Vector and Its Soluble Expression

Construction of GRIM-19 and Its Truncated Body Prokaryotic Expression Vector and Fusion Protein Induced Expression and Purification

Gene Construction, Expression and Activity Identification of Recombinant Anti-Her2 ScFv/FDT/caspase-6